Literature DB >> 8314309

Heterogeneous response to the growth factors [EGF, PDGF (bb), TGF-alpha, bFGF, IL-2] on glioma spheroid growth, migration and invasion.

P H Pedersen1, G O Ness, O Engebraaten, R Bjerkvig, J R Lillehaug, O D Laerum.   

Abstract

The effects of 5 different growth factors [EGF, PDGF(bb), TGF-alpha, bFGF and IL-2] were studied on tumour spheroids obtained from 5 different human glioma cell lines (U-251MG, D-263MG, D-37MG, D-54MG, GaMG). The expression of EGF and PDGF receptors as well as the endogenous production of TGF-alpha and PDGF were studied by Northern blot analyses. After growth-factor-exposure, tumour spheroid volume growth, and directional cell migration from the spheroids were studied. In addition, tumour-cell invasion was studied in vitro, where foetal rat-brain aggregates were used as a target for the tumour cells. In all the assays a common stimulator for most of the cell lines was EGF. The other growth factors had a more heterogeneous stimulatory effect. Tumour-cell invasion, cell growth and cell migration are biological properties which are not necessarily related to each other. This may explain why the tumours often responded differently to the growth factors in the various assay systems. Two of the cell lines studied were non-invasive (U-251MG, D-263MG). It is shown that these were stimulated both in the directional migration assay and in the spheroid-volume-growth assay. However, their non-invasive behaviour was not influenced by the growth factors studied.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8314309     DOI: 10.1002/ijc.2910560219

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  26 in total

1.  Proliferation and motility responses of primary and recurrent gliomas related to changes in epidermal growth factor receptor expression.

Authors:  M E Berens; M D Rief; J R Shapiro; D Haskett; A Giese; A Joy; S W Coons
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

2.  Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10.

Authors:  Toshiyuki Murai; Takayuki Miyauchi; Toshio Yanagida; Yasushi Sako
Journal:  Biochem J       Date:  2006-04-01       Impact factor: 3.857

3.  Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo.

Authors:  P C Brooks; R L Klemke; S Schon; J M Lewis; M A Schwartz; D A Cheresh
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

Review 4.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

5.  Heterogeneic modulation of malignant behavior in human glioma cells in defined and serum-containing media.

Authors:  H K Haugland; O B Tysnes
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-03       Impact factor: 2.416

6.  Granulocyte-colony stimulating factor promotes invasion by human lung cancer cell lines in vitro.

Authors:  X H Pei; Y Nakanishi; K Takayama; J Yatsunami; F Bai; M Kawasaki; K Wakamatsu; N Tsuruta; K Mizuno; N Hara
Journal:  Clin Exp Metastasis       Date:  1996-09       Impact factor: 5.150

7.  In situ analysis of integrin and growth factor receptor signaling pathways in human glioblastomas suggests overlapping relationships with focal adhesion kinase activation.

Authors:  Markus J Riemenschneider; Wolf Mueller; Rebecca A Betensky; Gayatry Mohapatra; David N Louis
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

8.  EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism.

Authors:  J E Segall; S Tyerech; L Boselli; S Masseling; J Helft; A Chan; J Jones; J Condeelis
Journal:  Clin Exp Metastasis       Date:  1996-01       Impact factor: 5.150

9.  Low Concentration Microenvironments Enhance the Migration of Neonatal Cells of Glial Lineage.

Authors:  Richard A Able; Celestin Ngnabeuye; Cade Beck; Eric C Holland; Maribel Vazquez
Journal:  Cell Mol Bioeng       Date:  2012-06       Impact factor: 2.321

10.  Human glioma cell culture: two FCS-free media could be recommended for clinical use in immunotherapy.

Authors:  Anne Clavreul; Isabelle Jean; Laurence Preisser; Agnès Chassevent; Anne Sapin; Sophie Michalak; Philippe Menei
Journal:  In Vitro Cell Dev Biol Anim       Date:  2009-06-16       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.